Sanjay Chanana

Sanjay Chanana

Active Director Designated Partner DIN 01184411
DIN 01184411 First appointment Apr 2000 Primary industry Business Outsourcing
Unlock full profile Investments · shareholding · contact details
Current companies 3 active board seats
Past companies 5 historical roles
Total affiliations 8 Since Apr 2000
Shareholding value •••• Premium profile

About Sanjay Chanana

Data last updated:

Sanjay Chanana is a Designated Partner at Shah Tc International Llp (since 2014), Designated Partner at Berg Healthcare Llp (since 2019) and Designated Partner at Stc International Llp (since 2018). The companies operate in Business Outsourcing, Pharma and Chemicals and Materials. The largest current company by reported revenue is Shah Tc International Llp at ₹56.12 Cr (FY 2024). Earlier, Sanjay Chanana was a Director at Shah Tc Overseas Private Limited (2000–2021) and Designated Partner at Jsn Pharmatech Llp (2012–2018) and 3 more.

DIN 01184411
Primary Designation Designated Partner
Industry Business Outsourcing
First Appointment 15 Apr 2000
Oldest Company Age 12 yrs
Largest company Shah Tc International Llp · ₹56.12 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner17 Jul 20142014₹56.12 Cr (FY 2024)Active
Designated Partner26 Feb 20192016Active
Designated Partner03 Apr 20182018Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Shah Tc Overseas Private Limited U74999DL2000PTC105046
Director15 Apr 20002000₹43.1 Lakh (FY 2024)Active
Designated Partner05 Dec 20122012Strike Off
Designated Partner20 Jan 20172017Active
Designated Partner13 Jul 20122012Strike Off
Designated Partner25 Jul 20142014Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Sanjay Chanana

NameDINCompanyDesignation
Neeraj Sharma08158763Shah Tc International Llp , Berg Healthcare Llp and 1 moreDesignated Partner
Ravi Kumar01184544Shah Tc International Llp , Berg Healthcare Llp and 1 moreDesignated Partner
Anshul Sikri00448268Berg Healthcare LlpDesignated Partner
Pochiraju Hanumath Subba Rao00448249Berg Healthcare LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Berg Healthcare Llp
Stc International Llp
Shah Tc International Llp
Shah Tc Overseas Private Limited
Premium access

Shareholding and investment profile for Sanjay Chanana

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sanjay Chanana

Sanjay Chanana currently holds 3 directorships: Shah Tc International Llp (Designated Partner, since 17 Jul 2014, revenue ₹56.12 Cr (FY 2024)); Berg Healthcare Llp (Designated Partner, since 26 Feb 2019); Stc International Llp (Designated Partner, since 03 Apr 2018).

Sanjay Chanana was first appointed on 15 Apr 2000 as Director at Shah Tc Overseas Private Limited. The most recent appointment on record is 26 Feb 2019 at Berg Healthcare Llp.

Sanjay Chanana held 5 earlier board appointments: Shah Tc Overseas Private Limited (Director, 15 Apr 2000 to 02 Apr 2021); Jsn Pharmatech Llp (Designated Partner, 05 Dec 2012 to 17 Aug 2018); Shah Tc Global Exim Llp (Designated Partner, 20 Jan 2017 to 17 Aug 2018); Zme Global India Llp (Designated Partner, 13 Jul 2012 to 17 Aug 2018); Green Dot Capsules Llp (Designated Partner, 25 Jul 2014 to 17 Aug 2018).

The current boards of Sanjay Chanana's companies include Neeraj Sharma (Shah Tc International Llp), Ravi Kumar (Shah Tc International Llp), Anshul Sikri (Berg Healthcare Llp), Pochiraju Hanumath Subba Rao (Berg Healthcare Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available